{"schema_version":"1","generated_at":"2026-10-30T13:44:30.971Z","data_as_of":null,"url":"https://www.findmykol.com/kol/april-sorrell","json_url":"https://www.findmykol.com/kol/april-sorrell/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"april-sorrell","name":"April Sorrell","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Bristol-Myers Squibb","institution_url":"https://www.findmykol.com/institution/bristol-myers-squibb","city":"San Antonio","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1023192085","openalex":"A5070504827"},"summary":"April Sorrell is an Oncology physician affiliated with Bristol-Myers Squibb. OpenAlex indexes 25 publications with 928 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":25,"cited_by_count":928,"h_index":12,"latest_activity_year":2024,"source":"works"},"trials":{"count":1,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00959283","title":"Study of Blood Samples From Newborns With Down Syndrome","status":"COMPLETED","role":"Overall official","sponsor":"Children's Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT00959283","trial_url":"https://www.findmykol.com/trial/NCT00959283"},{"nct":"NCT00411281","title":"Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder","phase":"PHASE3","status":"WITHDRAWN","role":"Overall official","sponsor":"Children's Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT00411281","trial_url":"https://www.findmykol.com/trial/NCT00411281"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"SANOFI PASTEUR INC.","program_year":2024,"amount_usd":18.52,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1023192085"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1023192085","source":"payments"},"publications":{"total":25,"shown":5,"withheld":20,"matched_by":"OpenAlex author record","recent":[{"title":"P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma","year":2021,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(21)02330-2","status":"verified"},{"title":"First Results of Iberdomide (IBER; CC-220) in Combination with Dexamethasone (DEX) and Daratumumab (DARA) or Bortezomib (BORT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2020-137743","status":"verified"},{"title":"Preclinical and Translational Data Support Development of Iberdomide in Combination with CD38- and SLAMF7-Directed Monoclonal Antibodies: Evidence for Rational Combinations","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2020-137667","status":"verified"},{"title":"Preclinical and Translational Support for Clinical Development of Iberdomide in Combination with Proteasome Inhibitors: Mechanism of Synergy in Clinical Trial CC-220-MM-001","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2020-137710","status":"verified"},{"title":"The VWRPY Domain Is Essential for RUNX1 Function in Hematopoietic Progenitor Cell Maturation and Megakaryocyte Differentiation","year":2018,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2018-99-113400","status":"verified"}],"source":"works"},"contact":{"address_1":"333 N SANTA ROSA ST","city":"San Antonio","state":"TX","zip":"782073108","phone":"210-704-4275","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1023192085","source":"identity"},"similar":[{"name":"Yixin Li","slug":"yixin-li","institution":"Bristol-Myers Squibb","url":"https://www.findmykol.com/kol/yixin-li","json_url":"https://www.findmykol.com/kol/yixin-li/profile.json"},{"name":"Alan J. Korman","slug":"alan-korman","institution":"Bristol-Myers Squibb","url":"https://www.findmykol.com/kol/alan-korman","json_url":"https://www.findmykol.com/kol/alan-korman/profile.json"},{"name":"Ray Hershberger","slug":"ray-hershberger","institution":"Bristol-Myers Squibb","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/ray-hershberger","json_url":"https://www.findmykol.com/kol/ray-hershberger/profile.json"},{"name":"Robert Plenge","slug":"robert-plenge","institution":"Bristol-Myers Squibb","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/robert-plenge","json_url":"https://www.findmykol.com/kol/robert-plenge/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":20}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-03-17","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}